Book a demo

Chemical intelligence powered by cypris.ai

5-Methanesulfonamido-6-(2,4-difluorothiophenyl)-1-indanone

[3-fluorosulfanyl-4-[6-(methanesulfonamido)-3-oxo-1,2-dihydroinden-5-yl]phenyl] thiohypofluorite

FormulaC16H13F2NO3S3
Mol. weight401.4608
PubChem CID23509770
InChIKeyAMRQIDIFRRETOE-UHFFFAOYSA-N
SMILESCS(=O)(=O)NC1=C(C=C2C(=C1)CCC2=O)C3=C(C=C(C=C3)SF)SF
36Patents
36Research papers
0Patents - last 3 years
0Papers - last 3 years

Who owns the IP

The organizations most actively patenting around this compound, ranked by referenced patent volume.

#AssigneePatents
1Perrigo Pharma International DAC12
2Alkermes Pharma Ireland Ltd10
3Glaxo Group Ltd4
4Nicox SA1
5SmithKline Beecham Corp1

Where innovation is concentrated

Patent classifications ranked by volume reveal the technical domains with the most active filing.

#CodeAreaPatents
1A61KMedicinal preparations34
2A61PTherapeutic activity (drug indications)34
3B82YNanotechnology3
4A61F1
5B23K1
6C07CAcyclic and carbocyclic compounds1
7C07DHeterocyclic compounds1
8C07J1
9C07KPeptides1

AI mapped opportunity space

This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.

See Cypris in action

Who's driving the science

The most-published authors working with this compound, alongside their primary affiliations.

#AuthorAffiliationPapers
1Jane A. MitchellRoyal Brompton Hospital4
2Paola PatrignaniUniversity of Chieti-Pescara4
3Chi-Chung ChanMerck Canada Inc. (Canada)3
4Daniel GuayMerck Canada Inc. (Canada)3
5Giovanna SantiniUniversity of Chieti-Pescara3
6Maria G. SciulliUniversity of Chieti-Pescara3
7Robert J. GordonMerck Canada Inc. (Canada)3
8Anita GrecoUniversity of Chieti-Pescara2
9Asokumar BuvanendranRush University Medical Center2
10Carlo PatronoUniversity of Chieti-Pescara2

Research leaders

This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.

See Cypris in action

The literature that defines it

The most-cited papers anchoring the scientific record for this compound.

Frequently asked questions

Common questions about this compound's patent and research landscape, answered from the underlying data.

What is the molecular formula and weight of this compound?

The molecular formula is C16H13F2NO3S3 with a molecular weight of 401.4608 g/mol.

Which organizations hold patents for this compound?

Perrigo Pharma International DAC holds the most patents with 12, followed by Alkermes Pharma Ireland Ltd with 10, Glaxo Group Ltd with 4, and Nicox SA and SmithKline Beecham Corp each with 1 patent.

What are the main research topics associated with this compound?

Research on this compound focuses on inflammatory mediators and NSAID effects, cyclooxygenase inhibition, pain mechanisms and treatments, and helicobacter pylori-related gastroenterology studies.

Which researchers have published the most papers on this compound?

Jane A. Mitchell from Royal Brompton Hospital and Paola Patrignani from University of Chieti-Pescara have each published 4 papers on this compound. Chi-Chung Chan, Daniel Guay, Giovanna Santini, Maria G. Sciulli, and Robert J. Gordon have each published 3 papers.

What patent classification codes are most frequently associated with this compound?

The most common patent classification codes are A61K and A61P, each appearing in 34 patents. B82Y appears in 3 patents, while A61F, B23K, C07C, C07D, C07J, and C07K each appear in 1 patent.

Turn any compound into a complete chemical intelligence landscape

Go beyond static compound data. Cypris resolves identities, patents, papers, and commercial signals into one AI-powered view - so your team can move from a single chemical question to a complete R&D, IP, and market landscape.

Schedule a free trial